Healthcare & Life Science

Force majeure, supply chain agreements, commercial contracts and remote customer service — these are just a few of the many areas businesses are rethinking due to the COVID-19 pandemic. For life science companies, these areas take on significant and often urgent meaning as they apply to the pharmaceutical production and…

Today, many have the misperception that M&A deals aren’t getting done because of the ongoing COVID-19 pandemic, or that the only deals closing are distressed deals that are unfavorable to the seller. But there’s more to the story. While we have seen a shift from a seller-favorable market to a…

KO client Nanospectra Biosciences, a medical device company that is pioneering a novel use of nanomedicine to destroy tumors without damaging adjacent healthy tissue, recently closed a $3 million Series B-1 financing with total approved capital of up to $6 million. The financing will be used for additional development and…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) has announced the expansion of its commercial practice with the addition of attorney Christine Hofmeister. Christine counsels health care, life science, technology and professional services clients on a variety of commercial and transactional matters. Christine specializes in drafting and negotiating a wide…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) has announced the expansion of its commercial and data privacy and security practices with the addition of attorney and data privacy expert Erin Locker. Erin joins KO Law Firm following several years at two international law firms. Erin’s practice focuses…

Businesses are facing significant challenges and uncertainty in light of the COVID-19 pandemic. Several new laws provide relief for businesses and employees, but businesses must still consider pre-existing legal and contractual factors during the current circumstances. The following guide gives businesses a solid foundation for navigating some of the most common…

In a tight labor market, it’s often the benefits and perks that help employers compete for talent. One key benefit an employer must consider is vacation. Should vacation be offered, and if so, how much and how should it be structured? What’s the real value of vacation to employees and…

Most life sciences companies negotiate numerous commercial contracts each year and must rely on big industry players for essential testing, supply and manufacturing partnerships. But these relationships can feel very unbalanced because large vendors seem to have far more negotiating power than any emerging company. Less favorable terms can have…